abrdn Life Sciences Investors (NYSE:HQL)
$ 15.25 0.08 (0.53%) Market Cap: 417.10 Mil Enterprise Value: 417.10 Mil PE Ratio: 11.38 PB Ratio: 0.95 GF Score: 42/100

abrdn Life Sciences Investors (HQL) Transcripts

    • 1